Drug-susceptible tuberculosis treatment success and associated factors in Ethiopia from 2005 to 2017: a systematic review and meta-analysis

被引:21
|
作者
Seid, Mohammed Assen [1 ]
Ayalew, Mohammed Biset [1 ]
Muche, Esileman Abdela [1 ]
Gebreyohannes, Eyob Alemayehu [1 ]
Abegaz, Tadesse Melaku [1 ]
机构
[1] Univ Gondar, Dept Clin Pharm, Gondar, Ethiopia
来源
BMJ OPEN | 2018年 / 8卷 / 09期
关键词
tuberclosis; treatment outcome; ethiopia; systematic review; meta-analysis; drug-susceptible; TREATMENT OUTCOMES; PULMONARY TUBERCULOSIS; NORTHEASTERN ETHIOPIA; ADDIS-ABABA; REGION; EASTERN;
D O I
10.1136/bmjopen-2018-022111
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Objectives The main aim of this study was to assess the overall tuberculosis (TB) treatment success in Ethiopia and to identify potential factors for poor TB treatment outcome. Design A systematic review and meta-analysis of published literature was conducted. Original studies were identified through a computerised systematic search using PubMed, Google Scholar and Science Direct databases. Heterogeneity across studies was assessed using Cochran's Q test and I-2 statistic. Pooled estimates of treatment success were computed using the random-effects model with 95% CI using Stata V.14 software. Results A total of 230 articles were identified in the systematic search. Of these 34 observational studies were eligible for systematic review and meta-analysis. It was found that 117750 patients reported treatment outcomes. Treatment outcomes were assessed by World Health Organization (WHO) standard definitions of TB treatment outcome. The overall pooled TB treatment success rate in Ethiopia was 86% (with 95% CI 83%_88%). TB treatment success rate for each region showed that, Addis Ababa (93%), Oromia (84%), Amhara (86%), Southern Nations (83%), Tigray (85%) and Afar (86%). Mainly old age, HIV co-infection, retreatment cases and rural residence were the most frequently identified factors associated with poor TB treatment outcome. Conclusion The result of this study revealed that the overall TB treatment success rate in Ethiopia was below the threshold suggested by WHO (90%). There was also a discrepancy in TB treatment success rate among different regions of Ethiopia. In addition to these, HIV co-infection, older age, retreatment cases and rural residence were associated with poor treatment outcome. In order to further improve the treatment success rate, it is strategic to give special consideration for regions which had low TB treatment success and patients with TB with HIV co-infection, older age, rural residence and retreatment cases.
引用
收藏
页数:12
相关论文
共 50 条
  • [1] Mycobacterium tuberculosis transmission from patients with drug-resistant compared to drug-susceptible TB: a systematic review and meta-analysis
    Kodama, Chiori
    Lange, Berit
    Olaru, Ioana D.
    Khan, Palwasha
    Lipman, Marc
    Seddon, James A.
    Sloan, Derek
    Grandjean, Louis
    Ferrand, Rashida Abbas
    Kranzer, Katharina
    [J]. EUROPEAN RESPIRATORY JOURNAL, 2017, 50 (04)
  • [2] Risk factors associated with drug-resistant tuberculosis in Ethiopia: A systematic review and meta-analysis
    Alemu, Ayinalem
    Bitew, Zebenay Workneh
    Diriba, Getu
    Gumi, Balako
    [J]. TRANSBOUNDARY AND EMERGING DISEASES, 2022, 69 (05) : 2559 - 2572
  • [3] Efficacy and safety of daily treatments for drug-susceptible pulmonary tuberculosis: a systematic review and network meta-analysis
    Imazu, Priscila
    Santos, Josiane M.
    Beraldi-Magalhaes, Francisco
    Fernandez-Llimos, Fernando
    Tonin, Fernanda S.
    Pontarolo, Roberto
    [J]. JOURNAL OF PHARMACY AND PHARMACOLOGY, 2022, 74 (06) : 905 - 917
  • [4] Factors predictive of the success of tuberculosis treatment: A systematic review with meta-analysis
    Chaves Torres, Ninfa Marlen
    Quijano Rodriguez, Jecxy Julieth
    Porras Andrade, Pablo Sebastian
    Arriaga, Maria Belen
    Martins Netto, Eduardo
    [J]. PLOS ONE, 2019, 14 (12):
  • [5] A Review of Moxifloxacin for the Treatment of Drug-Susceptible Tuberculosis
    Naidoo, Anushka
    Naidoo, Kogieleum
    McIlleron, Helen
    Essack, Sabiha
    Padayatchi, Nesri
    [J]. JOURNAL OF CLINICAL PHARMACOLOGY, 2017, 57 (11): : 1369 - 1386
  • [6] Adherence and associated factors of treatment regimen in drug-susceptible tuberculosis patients
    Bea, Sungho
    Lee, Hyesung
    Kim, Ju Hwan
    Jang, Seung Hun
    Son, Hyunjin
    Kwon, Jin-Won
    Shin, Ju-Young
    [J]. PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2021, 30 : 133 - 133
  • [7] Adherence and Associated Factors of Treatment Regimen in Drug-Susceptible Tuberculosis Patients
    Bea, Sungho
    Lee, Hyesung
    Kim, Ju Hwan
    Jang, Seung Hun
    Son, Hyunjin
    Kwon, Jin-Won
    Shin, Ju-Young
    [J]. FRONTIERS IN PHARMACOLOGY, 2021, 12
  • [8] Tuberculosis treatment delay and contributing factors within tuberculosis patients in Ethiopia: A systematic review and meta-analysis
    Fetensa, Getahun
    Wirtu, Dessalegn
    Etana, Belachew
    Wakuma, Bizuneh
    Tolossa, Tadesse
    Gugsa, Jilcha
    Gobena, Dabesa
    Fekadu, Ginenus
    Ragasa, Misganu Teshoma
    Ejeta, Eshetu
    [J]. HELIYON, 2024, 10 (07)
  • [9] Drug-related problems and associated factors in Ethiopia: a systematic review and meta-analysis
    Fuad Adem
    Jemal Abdela
    Dumessa Edessa
    Bisrat Hagos
    Abraham Nigussie
    Mohammed A. Mohammed
    [J]. Journal of Pharmaceutical Policy and Practice, 14
  • [10] Drug-related problems and associated factors in Ethiopia: a systematic review and meta-analysis
    Adem, Fuad
    Abdela, Jemal
    Edessa, Dumessa
    Hagos, Bisrat
    Nigussie, Abraham
    Mohammed, Mohammed A.
    [J]. JOURNAL OF PHARMACEUTICAL POLICY AND PRACTICE, 2021, 14 (01)